Blocking platelet aggregation inhibits thromboxane A2 formation by low dose agonists but does not inhibit phosphorylation and activation of cytosolic phospholipase A2 - Carroll, RC; Wang, XF; Lanza, F; Steiner, B; Kouns, WC (Thromb Res, 1997)